XML 50 R32.htm IDEA: XBRL DOCUMENT v3.22.4
Debt (Narrative) (Details) - USD ($)
$ in Thousands
12 Months Ended
Oct. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Debt Instrument [Line Items]      
Proceeds from Long-Term Lines of Credit   $ 7,500 $ 0
Innovatus Life Sciences Fund I, LP      
Debt Instrument [Line Items]      
Percentage of trailing twelve months revenue goal 50.00%    
Innovatus Life Sciences Fund I, LP | Draw down from 10-K filing to September 30, 2023      
Debt Instrument [Line Items]      
Proceeds from Long-Term Lines of Credit $ 7,500    
Innovatus Life Sciences Fund I, LP | Draw down from September 1, 2023 to December 15, 2023      
Debt Instrument [Line Items]      
Proceeds from Long-Term Lines of Credit 30,000    
Three months of trailing revenue 5,750    
Innovatus Life Sciences Fund I, LP | Draw down from September 1, 2024 to December 15, 2024      
Debt Instrument [Line Items]      
Proceeds from Long-Term Lines of Credit 20,000    
Three months of trailing revenue 9,000    
Loan and Security Agreement | Innovatus Life Sciences Fund I, LP      
Debt Instrument [Line Items]      
Maximum borrowing capacity 50,000    
Proceeds from Long-Term Lines of Credit $ 7,500    
Variable interest rate (as a percent) 5.50%    
Interest rate ( as a percent) 2.65%    
Term (in months) 3 months    
Final payment $ 300    
Percentage of final payment on original principal 4.50%    
Debt issuance costs and discounts $ 800